Culture Biosciences published data showing how Cytovance Biologics used Culture's cloud bioreactors to double titer in one week
| This week's Fierce Pharma is brought to you by Culture Biosciences.
Trouble viewing? Click here. |
Supplemental Bioreactor Capacity at Culture Bio Accelerates Bioprocess Development Read our case study to see how Cytovance Biologics used Culture Biosciences' bioreactor capacity to double titer in one week. Learn how supplementing internal capacity with Culture's cloud bioreactors can speed up project timelines. |
In this case study, learn: How our client's fermentation process was transferred, downscaled, modified and improved via a Design of Experiment (DOE), then verified and transferred back to the client in just a few experiments How this resulted in a two-fold increase in titer over the course of six experimental runs How rapid progress can be made by synergizing internal capacity with guaranteed capacity, resources and expertise in Culture’s Cloud Bioreactor Lab |
| If you no longer wish to receive communications from Culture Biosciences, please opt out here.
Want to reach 160,000+ Fierce Pharma subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Pharma's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.
Questex, LLC
685 3rd Avenue, 21st Floor
New York, NY 10017 |
|
